Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Current Cardiology Reviews|February 18, 2025
Prevalence and Adverse Outcomes of Iron Deficiency in Heart FailureHabeeb Abdulkareem Habeeb, Fraser Todd, Rohith Valsalan, et al.Drug and Alcohol Review|April 15, 2021
Validation of the French version of the Cannabis Use Disorder Identification Test-Revised and comparison with the Cannabis Abuse Screening Test for screening cannabis use disorder in a psychiatric sampleAmandine Luquiens, Aurélie Berger-Viergat, Agathe Larrieu, et al.Neuron|January 24, 2018
Normal CA1 Place Fields but Discoordinated Network Discharge in a Fmr1-Null Mouse Model of Fragile X SyndromeZoe Nicole Talbot, Fraser Todd Sparks, Dino Dvorak, et al.Journal of Human Hypertension|May 27, 2026
Comparison of unattended, attended and routine clinic systolic blood pressure measurements and determinants of blood pressure difference between attended and unattended BPFraser Todd, Joseph Rushton, Emily Hayashi, et al.ESC Heart Failure|January 7, 2021
Impact of COVID-19 on inpatient referral of acute heart failure: a single-centre experience from the south-west of the UKGemina Doolub, Chih Wong, Lynsey Hewitson, et al.World Journal of Surgery|May 13, 2021
Rates of Bile Acid Diarrhoea After Cholecystectomy: A Multicentre AuditAlexia Farrugia, Joseph Anthony Attard, Stuart Hanmer, et al.Journal of Psychopharmacology (Oxford, England)|June 24, 2023
The New Zealand drug harms ranking study: A multi-criteria decision analysisRose Crossin, Lana Cleland, Chris Wilkins, et al.Plos One|November 14, 2023
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trialTufail Bashir, Marcus Achison, Simon Adamson, et al.Plos One|October 20, 2023
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trialChristos Rossios, Tufail Bashir, Marcus Achison, et al.Plos One|August 2, 2024
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trialAlvin Shrestha, Tufail Bashir, Marcus Achison, et al.Pageof 5